
Europe - Frankfurt Stock Exchange - FRA:CBHD - DK0060448595 - Common Stock
The current stock price of CBHD.DE is 75.56 EUR. In the past month the price decreased by -2.7%. In the past year, price decreased by -29.15%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ESL.DE | ESSILORLUXOTTICA | 40.04 | 127.41B | ||
| EL.PA | ESSILORLUXOTTICA | 40.45 | 128.71B | ||
| 1EL.MI | ESSILORLUXOTTICA | 40.28 | 128.15B | ||
| GBT.PA | GUERBET | 24.26 | 187.07M | ||
| ALCJ.PA | CROSSJECT | N/A | 119.98M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 73.19M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 47.62M |
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
COLOPLAST-B
Holtedam 1-3
Humlebaek DK
Employees: 16628
Phone: 4549111111
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
The current stock price of CBHD.DE is 75.56 EUR. The price increased by 0.13% in the last trading session.
COLOPLAST-B (CBHD.DE) has a dividend yield of 4.21%. The yearly dividend amount is currently 2.95.
CBHD.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
26 analysts have analysed CBHD.DE and the average price target is 91.92 EUR. This implies a price increase of 21.65% is expected in the next year compared to the current price of 75.56.
The PE ratio for COLOPLAST-B (CBHD.DE) is 31.75. This is based on the reported non-GAAP earnings per share of 2.38 and the current share price of 75.56 EUR.
ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE. CBHD.DE has an excellent profitability rating, but there are some minor concerns on its financial health.
Over the last trailing twelve months CBHD.DE reported a non-GAAP Earnings per Share(EPS) of 2.38. The EPS decreased by -20.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.04% | ||
| ROA | 7.52% | ||
| ROE | 22.55% | ||
| Debt/Equity | 1.24 |
26 analysts have analysed CBHD.DE and the average price target is 91.92 EUR. This implies a price increase of 21.65% is expected in the next year compared to the current price of 75.56.
For the next year, analysts expect an EPS growth of 46.79% and a revenue growth 4.89% for CBHD.DE